UNITED THERAPEUTICS (UTH MU) stock market data APIs
€465.4207
0(0%)
as of March 27, 2026
Try our APIs with
free plan!
UNITED THERAPEUTICS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for UTH.MU.
Prev. Close
465.4207
Open
465.4207
High
465.4207
Low
465.4207
52 wk Range
240.7-469.95
Market Cap
7 520 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get UNITED THERAPEUTICS data using free add-ons & libraries
Get UNITED THERAPEUTICS Fundamental Data
UNITED THERAPEUTICS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
UNITED THERAPEUTICS News
New
Cantor Fitzgerald Raises United Therapeutics (UTHR) Price Target to $625
United Therapeutics Corporation (NASDAQ:UTHR) is one of the 15 Set-It-and-Forget-It Stocks to Buy in 2026.Cantor Fitzgerald Raises United Therapeutics (UTHR) Price Target to $625 On March 12, 2026, C...
Is MannKind Corporation (MNKD) One of the Popular Penny Stocks on Robinhood to Buy?
MannKind Corporation (NASDAQ:MNKD) is one of the popular penny stocks on Robinhood to buy. On March 11, MannKind Corporation (NASDAQ:MNKD) CEO Michael Castagna and CFO Chris Prentiss presented at the ...
This Biotech Holds Up In Buy Zone Despite Falling Market
While the major indexes are showing major declines this week, United Therapeutics is holding up in a buy zone. Shares are still actionable now. Continue Reading
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for United Therapeutics (UTHR). Shares have added about 5.7% in that time frame, outperforming the S&P 500. Will the recent positive trend con...
Get UNITED THERAPEUTICS fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
